Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection

UNC Libraries(2020)10.17615/jpe8-9h04Source: DataRank Database

Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.27)OA: greenTopics (39)IDs (PubMed, OpenAlex)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

K.J. Oestreich,M. Beck,K.M. Gowdy,Anushri Pal ORCID,S.R. Shaikh

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W4287915949

National Institutes of Health

Grant: 5R01ES031378-02

Dietary DHA mitigates ozone induced pulmonary inflammation

National Institutes of Health

Grant: 7R01AT008375-04

Suppressing inflammation and boosting humoral immunity with n-3 PUFAs

National Institutes of Health

Grant: 7R01AI134972-03

Identifying novel regulatory pathways underlying T helper 1 cell immune responses

FWCI

0.27

Citation Percentile

0.6%

Citation Trend

2022

greenLicense: CC BY

repositoryhttps://doi.org/10.17615/jpe8-9h04

https://doi.org/10.3389/fimmu.2020.01997

https://www.frontiersin.org/articles/10.3389/fimmu.2020.01997/pdf

https://dx.doi.org/10.17615/jpe8-9h04

https://pubmed.ncbi.nlm.nih.gov/32983141

Fields of Study

Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityCancer, Stress, Anesthesia, and Immune Response0301 basic medicine03 medical and health sciences

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Adverse effectMedicineObesity2019-20 coronavirus outbreakVirologyPandemicIntensive care medicineImmunologyInternal medicineOutbreakDocosahexaenoic AcidsprotectinsPneumonia, ViralComorbidityresolvinsLinoleic AcidBetacoronavirusRisk FactorsantibodiesHumansPandemicsInflammationSARS-CoV-2COVID-19lipoxinsRC581-607maresinsEicosapentaenoic AcidDisease SusceptibilityImmunologic diseases. AllergyMorbidityCoronavirus Infections

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 0: Zero hunger